Fatigue in primary Sjögren's syndrome - A link to sickness behaviour in animals?

Brain, Behavior, and Immunity

Volumn 23, Issue 8, 2009, Pages 1104-1108

  Harboe, Erna ^a   Tjensvoll, Anne Bolette ^a   Vefring, Hege K ^a   Gøransson, Lasse G ^a,c   Kvaløy, Jan Terje ^a,b   Omdal, Roald ^a,c  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF STAVANGER   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Fatigue; Interleukin 1Ra; Primary Sj gren's syndrome; Sick behaviour

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1 RECEPTOR TYPE II; INTERLEUKIN 1BETA;

ADULT; AGE; ARTICLE; AUTOIMMUNE DISEASE; BECK DEPRESSION INVENTORY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SJOEGREN SYNDROME; VISUAL ANALOG SCALE;

ADULT; AGED; DEPRESSION; FATIGUE; FEMALE; HUMANS; ILLNESS BEHAVIOR; INFLAMMATION MEDIATORS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RECEPTORS, INTERLEUKIN-1 TYPE II; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 72649094481     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.06.151     Document Type: Article

References (37)

1. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue, 2007. Measurement of fatigue in systemic lupus erythematosus: a systematic review. Arthritis Rheum. 57, 1348-1357.
2. Anandacoomarasamy, A., Caterson, I.D., Leibman, S., Smith, G.S., Sambrook, P.N., Fransen, M., March, L.M., 2009. Influence of BMI on health-related quality of life: comparison between an obese adult cohort and age-matched population norms. Obesity (Silver Spring), doi:10.1038/oby.2009.121.
3. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol. 16 (1998) 27-55
4. Banks W.A., Kastin A.J., and Broadwell R.D. Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation 2 (1995) 241-248
5. Beck A.T., and Beamesderfer A. Assessment of depression: the depression inventory. Mod. Probl. Pharmacopsychiatry 7 (1974) 151-169
6. Bluthe R.M., Laye S., Michaud B., Combe C., Dantzer R., and Parnet P. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur. J. Neurosci. 12 (2000) 4447-4456
7. Bowman S.J., Ibrahim G.H., Holmes G., Hamburger J., and Ainsworth J.R. Estimating the prevalence among Caucasian women of primary Sjogren's syndrome in two general practices in Birmingham, UK. Scand. J. Rheumatol. 33 (2004) 39-43
8. Crestani F., Seguy F., and Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 542 (1991) 330-335
9. Dantzer R. Cytokine-induced sickness behavior: where do we stand?. Brain Behav. Immun. 15 (2001) 7-24
10. Dellalibera-Joviliano R., Dos Reis M.L., Cunha Fde Q., and Donadi E.A. Kinins and cytokines in plasma and cerebrospinal fluid of patients with neuropsychiatric lupus. J. Rheumatol. 30 (2003) 485-492
11. Dinarello C.A. The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20 (2002) S1-S13
12. Dinarello C.A. Interleukin-1 family. In: Thompson A.L., and Lotze M.T. (Eds). The Cytokine Handbook vol. II (2003), Academic Press, San Diego 643-668
13. Ferrucci L., Corsi A., Lauretani F., Bandinelli S., Bartali B., Taub D.D., Guralnik J.M., and Longo D.L. The origins of age-related proinflammatory state. Blood 105 (2005) 2294-2299
14. Fox R.I. Sjogren's syndrome. Lancet 366 (2005) 321-331
15. Gabay C., Smith M.F., Eidlen D., and Arend W.P. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J. Clin. Invest. 99 (1997) 2930-2940
16. Goligher E.C., Pouchot J., Brant R., Kherani R.B., Aviña-Zubieta J.A., Lacaille D., Lehman A.J., Ensworth S., Kopec J., Esdaile J.M., and Liang M.H. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J. Rheumatol. 35 (2008) 635-642
17. Goransson L.G., Herigstad A., Tjensvoll A.B., Harboe E., Mellgren S.I., and Omdal R. Peripheral neuropathy in primary sjogren syndrome: a population-based study. Arch. Neurol. 63 (2006) 1612-1615
18. Huskinsson E.C. Analogue scales. In: Melzack R. (Ed). Pain Measurement and Assessment (1983), Raven Press, New York 33-40
19. Kabasakal Y., Kitapcioglu G., Turk T., Oder G., Durusoy R., Mete N., Egrilmez S., and Akalin T. The prevalence of Sjogren's syndrome in adult women. Scand. J. Rheumatol. 35 (2006) 379-383
20. Kent S., Bret-Dibat J.L., Kelley K.W., and Dantzer R. Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20 (1996) 171-175
21. Krupp L.B., LaRocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch. Neurol. 46 (1989) 1121-1123
22. Laye S., Parnet P., Goujon E., and Dantzer R. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res. Mol. Brain Res. 27 (1994) 157-162
23. Lindberg C., Chromek M., Ahrengart L., Brauner A., Schultzberg M., and Garlind A. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease. Neurochem. Int. 46 (2005) 551-557
24. Lwin C.T., Bishay M., Platts R.G., Booth D.A., and Bowman S.J. The assessment of fatigue in primary Sjogren's syndrome. Scand. J. Rheumatol. 32 (2003) 33-37
25. Natelson B.H., Weaver S.A., Tseng C.L., and Ottenweller J.E. Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin. Diagn. Lab. Immunol. 12 (2005) 52-55
26. Omdal R., Mellgren S.I., Koldingsnes W., Jacobsen E.A., and Husby G. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. J. Rheumatol. 29 (2002) 482-486
27. Omdal R., and Gunnarsson R. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis - a pilot study. Rheumatology 25 (2005) 481-484
28. Rinehart J., Hersh E., Issell B., Triozzi P., Buhles W., and Neidhart J. Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940. Cancer Invest. 15 (1997) 403-410
29. Schubert C., Hong S., Natarajan L., Mills P.J., and Dimsdale J.E. The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review. Brain Behav. Immun. 21 (2007) 413-427
30. Shiozaki T., Hayakata T., Tasaki O., Hosotubo H., Fuijita K., Mouri T., Tajima G., Kajino K., Nakae H., Tanaka H., Shimazu T., and Sugimoto H. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23 (2005) 406-410
31. Silvermann L.M., and Christenson R.H. Amino acids and proteins. Tietz Fundamentals of Clinical Chemistry. fourth ed. (1996), WB Saunders, Philadelphia pp. 240-282
32. Sriwatanakul K., Kelvie W., Lasagna L., Calimlim J.F., Weis O.F., and Mehta G. Studies with different types of visual analog scales for measurement of pain. Clin. Pharmacol. Ther. 34 (1983) 234-239
33. Tarkowski E., Liljeroth A.M., Nilsson A., Minthon L., and Blennow K. Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 12 (2001) 314-317
34. Trysberg E., Carlsten H., and Tarkowski A. Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement. Lupus 9 (2000) 498-503
35. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., and Weisman M.H. European Study Group on Classification Criteria for Sjögren's Syndrome, 2002.Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61 (2002) 554-558
36. Willeke P., Schotte H., Schluter B., Erren M., Becker H., Dyong A., Mickholz E., Domschke W., and Gaubitz M. Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjogren's syndrome. Ann. Rheum. Dis. 62 (2003) 359-362
37. Yokoyama T., Oda M., and Seino Y. Interleukin-1 beta and interleukin-1 receptor antagonist levels in cerebrospinal fluid of aseptic meningitis patients. Pediatr. Allergy Immunol. 9 (1998) 91-96